UK academic-SME collaborations bring new tech to drug discovery
Drug Discovery World
MAY 28, 2024
The SMEs partnering with the Crick Perha Pharmaceuticals are collaborating with Victor Tybulewicz and the Immune Cell Biology Laboratory & Down Syndrome Laboratory, looking at DYRK1A inhibition as a pharmacological treatment for congenital heart defects in down syndrome.
Let's personalize your content